Stock listing
Delta-fly Pharma, Inc.
Selected listing: 4598 · TSE · JPY · JP
Delta-fly Pharma, Inc. (Tokyo:4598), Health Technology. Latest release Aug 31, 2026: Update on the Phase 2／3 Clinical Trial of DFP-17729.
- Ticker
- Tokyo:4598
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Delta-fly Pharma, Inc.
Delta-fly Pharma, Inc. is a public company listed under the ticker 4598 in the Japanese market. Delta-fly Pharma focuses on developing innovative pharmaceutical solutions.
Latest news from Delta-fly Pharma, Inc.
Update on the Phase 2／3 Clinical Trial of DFP-17729
August 31, 2026
Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 with Venetoclax
March 3, 2025
Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax
December 9, 2024
Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
December 4, 2024
Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
November 26, 2024
Research Delta-fly Pharma, Inc.
Delta-fly Pharma, Inc. company profile
View the public company page for Delta-fly Pharma, Inc. on 6ix.
Delta-fly Pharma, Inc. news
Read company news and market updates connected to Delta-fly Pharma, Inc..
Delta-fly Pharma, Inc. investor events
Find investor webinars, events, and replay context for Delta-fly Pharma, Inc..